General
Preferred name
OXINIACIC ACID
Synonyms
Nicotinic acid 1-oxide ()
oxiniacic-acid ()
Nicotinic acid N-oxide ()
Oxiniacic acid, Nicotinic acid 1-oxide ()
Acide oxiniacique ()
NSC-93890 ()
Acido oxiniacico ()
P&D ID
PD000169
CAS
2398-81-4
Tags
available
drug
Drug Status
investigational
approved
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Nicotinic acid N-oxide can be used for research on hyperlipidemia.
PRICE
29
DESCRIPTION
Nicotinic acid N-oxide is used to treat hyperlipoidemia.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Nicotinic acid N-oxide is used to treat hyperlipoidemia. It inhibits nicotinic acetylcholine receptors with Ki values of 3.16µM.
(Enamine Bioactive Compounds)
DESCRIPTION
Nicotinic acid N-oxide (Nicotinic acid 1-oxide) is a nicotinic acid derivative, used to treat hyperlipoidemia.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
BOC Sciences Bioactive Compounds
ChEMBL Drugs
Drug Repurposing Hub
DrugCentral
DrugCentral Approved Drugs
Enamine Bioactive Compounds
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
NPC Screening Collection
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
28
Molecular Weight
139.03
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
1
Rotatable Bonds
1
Ring Count
1
Aromatic Ring Count
1
cLogP
0.02
TPSA
64.24
Fraction CSP3
0.0
Chiral centers
0.0
Largest ring
6.0
QED
0.44
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Drug Derivative
Solubility
Soluble in DMSO
Source data

